Intersect ENT launches trial of drug-coated sinus balloon

Intersect ENT (NSDQ:XENT) said today that it enrolled the first patient in a trial of its Ascend drug-coated sinus balloon. The Menlo Park, Calif.-based company’s device is designed to deliver mometasone furoate directly to a person’s sinuses at the time of dilation. Get the full story at our sister site, Drug Delivery Business News. The post Intersect ENT launches trial of drug-coated sinus balloon appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Drug-Device Combinations Featured Otolaryngology Ear, Nose & Throat Pharmaceuticals Wall Street Beat intersectent Source Type: news